If a drug inhibits pancreatic beta cell glucokinase in a patient with Type 2 diabetes already exhibiting insulin resistance, which consequence follows?

💡 Explanation

Inhibiting glucokinase impairs the initial step of glucose metabolism in pancreatic beta cells, because this reduces ATP production which triggers insulin release. Therefore, glucose-stimulated insulin secretion decreases, rather than increases, while GLUT4 translocation and hepatic glucose production are not directly stimulated.

• If an individual with iodine deficiency develops increased thyroid-stimulating hormone (TSH) levels, which compensatory change is least likely?
• If a patient has a mutation causing constitutive activation of thyroid stimulating hormone (TSH) receptors, why does thyroid hormone production not increase indefinitely?
• Why does the body absorb more free fatty acids in the small intestine compared to the stomach, even though both organs experience peristalsis?
• Why does a person with carpal tunnel syndrome experience decreased touch sensitivity specifically in the thumb, index, and middle fingers, rather than the entire hand?
• A patient with advanced heart failure experiences worsening edema in their legs. Which mechanism explains why the Starling forces lead to increased fluid accumulation in the interstitial space?
• What causes delayed implantation in mammals exhibiting embryonic diapause during reproduction?